Elmiron Lawsuit: Seeking Justice for Victims
Elmiron Lawsuit: Seeking Justice for Victims
Understanding the Elmiron Risk
The Elmiron drug, formerly known as methylene blue, has been linked to significant and potentially irreversible ocular damage, specifically pigmentary retinopathy. Numerous individuals have reported vision loss, including reduced central vision, and in some cases, complete blindness, following prolonged use of this medication. At Albenze Law Group, we recognize the devastating impact this drug has had on countless lives and are dedicated to providing comprehensive legal support to those affected.
Years of Experience & Specialized Expertise
Our firm boasts years of experience in representing individuals harmed by pharmaceutical products. We’ve established a specialized team focused on Elmiron-related lawsuits, possessing deep knowledge of the scientific evidence, regulatory actions, and potential legal strategies.
- What Causes the Vision Loss? The exact mechanism of damage is still being investigated, but evidence suggests that methylene blue, when metabolized, produces reactive oxygen species that damage the retina.
- Legal Options We explore all available legal avenues, including product liability lawsuits against the manufacturer (Vert Pharmaceuticals and now Merck & Co.) and potential claims under various regulations.
- Personalized Approach We understand that every case is unique. We take a personalized approach, diligently investigating your specific circumstances and developing a tailored legal strategy to maximize your chances of recovery.
Award-Winning Service Our commitment to achieving justice for our clients is recognized through our award-winning service.
Serving Elyria, Ohio & Beyond
We are strategically located in Elyria, Ohio, allowing us to effectively represent clients throughout Ohio, including Cleveland, Akron, and Youngstown. Our legal team is prepared to assist clients across the state.
Contact us today to discuss your case and explore your legal options.











